Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT04130919 · TERMINATED
Trial details
- NCT number
- NCT04130919
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2021-02-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.